Novel Anesthesia Monitor Evaluates Neuromuscular Transmission
By HospiMedica International staff writers Posted on 26 Oct 2019 |
Image: The Stimpod NMS450X NMT patient monitor (Photo courtesy of Xavant Technology).
A new portable neuromuscular transmission (NMT) monitor for use during anesthesia features both acceleromyography (AMG) and electromyography (EMG) modalities.
The Xavant Technology (Pretoria, South Africa) Stimpod NMS450X monitor enables objective NMT monitoring via AMG (with a reusable sensor) or EMG (with a disposable sensor) in order to manage patients undergoing neuromuscular block during surgery, or in the intensive care unit (ICU). OneTouch NMT technology enables the user to monitor an entire case, from electrode placement to extubation; Stimpod will automatically identify optimal electrode placement, assign the appropriate supramaximal current, begin Train of For (TOF) monitoring, and move to Post Tetanic Count (PTC) when a deep/profound block is achieved.
When the patient begins the reversal process, the Stimpod monitor will automatically reinitiate TOF monitoring until the patient is over 90% recovered. No manual intervention is required to manage the process. Along the way, the Stimpod will detect and notify the user of the depth of the neuromuscular blockade. Additional features include Double Burst (DB), Tetanus, and Twitch stimulation modes for accurate NMT monitoring during more restrictive surgical cases, such as robotic surgery, where restricting the hands is common.
“We believe quantitative or objective monitoring of patients who are undergoing neuromuscular block for surgery should be the standard of care. Our goal is to provide physicians with the most optimal and efficient tools to achieve that standard,” said Corlius Birkill, CEO of Xavant Technology. “By offering, for the first time, anesthesiologists and clinicians a choice in using either AMG or EMG, we can give them unparalleled clinical and budgetary benefits.”
Intraoperative NMT involves the use of electrophysiological methods such as electroencephalography (EEG), AMG, EMG, and evoked potentials to monitor the functional integrity of neural structures during surgery. The purpose is to reduce the risk to the patient of iatrogenic damage to the nervous system, and to provide functional guidance to the surgeon and anesthesiologist.
Related Links:
Xavant Technology
The Xavant Technology (Pretoria, South Africa) Stimpod NMS450X monitor enables objective NMT monitoring via AMG (with a reusable sensor) or EMG (with a disposable sensor) in order to manage patients undergoing neuromuscular block during surgery, or in the intensive care unit (ICU). OneTouch NMT technology enables the user to monitor an entire case, from electrode placement to extubation; Stimpod will automatically identify optimal electrode placement, assign the appropriate supramaximal current, begin Train of For (TOF) monitoring, and move to Post Tetanic Count (PTC) when a deep/profound block is achieved.
When the patient begins the reversal process, the Stimpod monitor will automatically reinitiate TOF monitoring until the patient is over 90% recovered. No manual intervention is required to manage the process. Along the way, the Stimpod will detect and notify the user of the depth of the neuromuscular blockade. Additional features include Double Burst (DB), Tetanus, and Twitch stimulation modes for accurate NMT monitoring during more restrictive surgical cases, such as robotic surgery, where restricting the hands is common.
“We believe quantitative or objective monitoring of patients who are undergoing neuromuscular block for surgery should be the standard of care. Our goal is to provide physicians with the most optimal and efficient tools to achieve that standard,” said Corlius Birkill, CEO of Xavant Technology. “By offering, for the first time, anesthesiologists and clinicians a choice in using either AMG or EMG, we can give them unparalleled clinical and budgetary benefits.”
Intraoperative NMT involves the use of electrophysiological methods such as electroencephalography (EEG), AMG, EMG, and evoked potentials to monitor the functional integrity of neural structures during surgery. The purpose is to reduce the risk to the patient of iatrogenic damage to the nervous system, and to provide functional guidance to the surgeon and anesthesiologist.
Related Links:
Xavant Technology
Latest Critical Care News
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia
- AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration
- Preventive PCI for High-Risk Coronary Plaques Reduces Cardiac Events
- AI Diagnostic Tool Guides Rapid Diagnosis and Prediction of Sepsis
- World's First AI-Powered Sepsis Alert System Detects Sepsis in One Minute